Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Martinez

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Journal of Virology|September 15, 2021
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2Lisa H Tostanoski, Lisa E Gralinski, David R Martinez, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Science (New York, N.Y.)|July 2, 2021
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Plos Pathogens|February 22, 2023
Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elementsJohn N Snouwaert, Leigh A Jania, Trang Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccineLuciana Conde, Valter Monteiro, Joao Cr Freitas, et al.
Science Translational Medicine|September 27, 2023
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirusLongping V Tse, Yixuan J Hou, Elizabeth McFadden, et al.
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Nature Communications|July 7, 2016
Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virusRuijun Zhang, David R Martinez, Quang N Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionWei Li, Chuan Chen, Aleksandra Drelich, et al.
Plos One|July 6, 2017
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144Lautaro G Perez, David R Martinez, Allan C deCamp, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Journal of Virology|September 15, 2021
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2Lisa H Tostanoski, Lisa E Gralinski, David R Martinez, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Chimeric spike mRNA vaccines protect against Sarbecoviru<i>s</i> challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Science (New York, N.Y.)|July 2, 2021
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Sarah R Leist, et al.
Plos Pathogens|February 22, 2023
Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elementsJohn N Snouwaert, Leigh A Jania, Trang Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Serotype skewing and immune imprinting shape response to the tetravalent dengue virus Qdenga vaccineLuciana Conde, Valter Monteiro, Joao Cr Freitas, et al.
Science Translational Medicine|September 27, 2023
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirusLongping V Tse, Yixuan J Hou, Elizabeth McFadden, et al.
The Journal of Experimental Medicine|November 19, 2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivoAlexandra Schäfer, Frauke Muecksch, Julio C C Lorenzi, et al.
Nature Communications|July 7, 2016
Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virusRuijun Zhang, David R Martinez, Quang N Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionWei Li, Chuan Chen, Aleksandra Drelich, et al.
Plos One|July 6, 2017
V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144Lautaro G Perez, David R Martinez, Allan C deCamp, et al.
Pageof 12